Minimally invasive surgeries/procedures are rapidly becoming one of the leading approaches used to treat various cardiovascular ailments, especially blood clots. Over the years, a majority of the minimally invasive cardiovascular surgeries have been increasingly using atherectomy and thrombectomy devices to increase the success rate of the surgeries and to reduce procedure and recovery time. Atherectomy devices are primarily used to debulk or clear blood vessels which have been occluded by fat accumulation (atherosclerosis plaque). Thrombectomy devices, on the other hand, are used to extract, excise, or disrupt blood clots. They use a variety of methods to safely remove emboli in any part of the body.

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Global Atherectomy and Thrombectomy

Devices Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

07. Market Segmentation by Category

07.1 Atherectomy Devices

07.2 Thrombectomy Devices

07.3 Five Forces Analysis

08. Geographical Segmentation of Global

Atherectomy and Thrombectomy

Devices Market

08.1 Atherectomy and Thrombectomy Devices

Market in the Americas

08.1.1 Market Size and Forecast

08.2 Atherectomy and Thrombectomy Devices

Market in the EMEA Region

08.2.1 Market Size and Forecast

08.3 Atherectomy and Thrombectomy Devices

Market in the APAC Region

08.3.1 Market Size and Forecast

09. Global Atherectomy Devices Market

Landscape

09.1 Market Overview

09.2 Market Size and Forecast

10. Market Segmentation by Device Type

11. Geographical Segmentation of Global

Atherectomy Devices Market

11.1 Key Leading Countries

11.1.1 USA

11.1.2 Germany

11.1.3 France

12. Global Thrombectomy Devices Market

Landscape

12.1 Market Overview

12.2 Market Size and Forecast

13. Market Segmentation by Application

14. Geographical Segmentation of Global

Thrombectomy Devices Market

14.1 Key Leading Countries

14.1.1 USA

14.1.2 Germany

14.1.3 Japan

15. Buying Criteria

16. Market Growth Drivers

17. Drivers and their Impact

18. Market Challenges

19. Impact of Drivers and Challenges

20. Market Trends

21. Trends and their Impact

22. Vendor Landscape

22.1 Competitive Scenario

22.1.1 Key News

22.1.2 Mergers and Acquisitions

22.2 Market Share Analysis 2013

22.3 Other Prominent Vendors

23. Key Vendor Analysis

23.1 Bayer AG

23.1.1 Business Overview

23.1.2 Business Segmentation

23.1.3 Key Information

23.1.4 SWOT Analysis

23.2 Boston Scientific Corp.

23.2.1 Business Overview

23.2.2 Business Segmentation

23.2.3 Key Information

23.2.4 SWOT Analysis

23.3 Cardiovascular Systems Inc

23.3.1 Business Overview

23.3.2 Key Information

23.3.3 SWOT Analysis

23.4 Covidien plc

23.4.1 Business Overview

23.4.2 Business Segmentation

23.4.3 Key Information

23.4.4 SWOT Analysis

23.5 Spectranetics Corp.

23.5.1 Business Overview

23.5.2 Business Segmentation

23.5.3 Key Information

23.5.4 SWOT Analysis